Release Date: Monday, November 27, 2023
       Expiration Date: Tuesday, November 27, 2024


Human papillomavirus (HPV) is a common virus that is linked to several types of cancers and genital warts. The virus infects an overwhelming majority of men and women during their lifetimes. According to the CDC, there are an estimated 13 million new infections each year, with most of these new infections occurring among 15- to 24-year-olds. Cervical cancer is the most common HPV-associated cancer, but the virus is also linked to cancers of the vulva, vagina, penis, anus, and oropharynx. 

Vaccination against HPV remains the most effective approach to prevent HPV-related cancers and can be given to children, adolescents, and young adults. Long-term population-based studies are giving an indication of the broad impact of HPV vaccination in reducing cervical cancer incidence. Despite the safety and efficacy of HPV vaccination, uptake of the vaccine lags behind other immunizations given to adolescents and adults. This can be attributed to a number of factors, including vaccine hesitancy, misinformation, and healthcare disparities. Primary care providers (PCPs) are key players in ensuring their patients remain up-to-date on vaccinations. PCPs are often the first point of provider contact for well and sick visits and provide a trusted resource for medical information. Knowledge of vaccination barriers is critical for PCPs to offer education that is personalized for each patient and/or caregiver in order to build acceptance and maximize protection against HPV infection and associated complications. This activity will review the current burden of HPV-related cancers, assess the latest clinical evidence linking HPV vaccination with cancer prevention, and discuss effective communication strategies to ensure that patients and/or caregivers understand the value of vaccination.


This activity is designed as a comprehensive approach to address the practice needs of primary care providers, including primary care physicians, osteopathic physicians, physician assistants, nurse practitioners, and allied healthcare professionals, who are at forefront of caring for adult patients eligible for immunizations and/or at risk for vaccine-preventable diseases.




At the conclusion of the educational activity, the learner should be able to:

  • Explain the current incidence of human papillomavirus (HPV)-associated cancers in men and women and how the incidence has changed since the availability of HPV vaccination
  • Recognize how patient barriers to HPV vaccination can differ depending on age, gender, and other patient factors
  • Utilize communication strategies designed to educate vaccine-eligible patients in an age-appropriate and gender-neutral manner about the risks of HPV infection and benefits of vaccination

This online presentation builds competence, confidence, and skills in the understanding of how to utilize patient-provider communication and therapeutic approaches to improve patient health outcomes while reducing disease burden.

Introduction: Recognizing the Burden of HPV-related Cancers
Epidemiology of HPV
  1. HPV infection in the US – transmission and prevalence
  2. HPV-related cancers – types and incidence
  3. HPV vaccine – safety and efficacy
Maximizing Protection Against HPV
  1. Current ACIP recommendations
  2. Overcoming barriers to gain vaccine acceptance
  3. Recognizing and addressing health disparities


Margot L. Savoy MD, MPH, FAAFP
Associate Professor (adj), Family and Community Medicine
Associate Professor (adj), Urban Bioethics & Population Health
The Lewis Katz School of Medicine at Temple University
Associate Professor (adj), Oral Health
Maurice Kornberg School of Dentistry at Temple University
Philadelphia, PA


Accreditation and Credit Designation Statement


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Center for Independent Healthcare Education (Center) and Vemco MedEd. Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Center designates this Enduring material for a maximum of 1.25  AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

Physician Assistants 

AAPA accepts AMA PRA Category 1 Credit™ for the PRA from organizations accredited by ACCME.

Nurse Practitioner

Nurse Practitioners will receive certificate of AMA PRA Category 1 Credit™ as this is an ACCME accredited program and its accreditation is recognized by Nurse Practitioner boards.

For questions regarding the accreditation of this activity, please contact us at  

Method of Participation and Instruction for Credit

  1. Review the entire CME information including target audience, learning objectives, and disclosures.
  2. Review the activity in its entirety.
  3. Complete the Online Post Test, Evaluation, and Credit Application form
  4. Please note that to receive credit you must achieve a score of at least 75%.
  5. Certificate of Credit will be emailed to you within 4 weeks.

Disclosure of Financial Relationships with Ineligible Companies

Center for Independent Healthcare Education and Vemco MedEd fully comply with the Standards for Integrity and Independence in Accredited Continuing Education in development of CME activities. We require the full disclosure of financial relationships with ineligible companies from all individuals in a position to influence the content of a certified activity, in any amount occurring within the past 24 months. All relevant financial relationship is identified by the provider and mitigated to prevent inserting commercial bias into content. All identified relevant financial relationships are disclosed to the learners prior to the activity. The faculty is further required to disclose discussion of off-label uses in their presentations.


Dr. Margot Savoy has the following relevant financial relationships with ineligible companies to disclose:

    Advisory Board: Novo Nordisk; Eisai Inc.
    Author: Merck & Co., Inc. 

Dr. Savoy does not discuss any off-label use. 

All relevant financial relationships have been mitigated. No (other) speakers, authors, planners or content reviewers have any relevant financial relationships to disclose. Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.  

There is no fee to participate in this activity.

System Check
Please e-mail any questions or concerns to

Copyright Statement
Copyright © 2023 Vemco MedEd. All Rights Reserved. Permission for accreditation use granted to Center for Independent Healthcare Education.

Privacy Policy

Joint Providership
This activity is jointly provided by Center for Independent Healthcare Education and Vemco MedEd.

Commercial Support
This activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.


By clicking below, I acknowledge that I have read the entire CME information.